newsfilter
← Latest News
PR Newswire·

Inhibrx Reports Second Quarter 2026 Financial Results

SAN DIEGO, Aug. 13, 2026 /PRNewswire/ -- Inhibrx Biosciences, Inc. (NASDAQ:INBX) ("Inhibrx" or the "Company") today reported financial results for the second quarter of 2026. The biopharmaceutical